{"id":"F2010L03305","name":"Therapeutic Goods (Listing) Notice 2010 (No. 4)","slug":"therapeutic-goods-listing-notice-2010-no-4","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":85615,"registerId":"commonwealth-F2010L03305-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2010 (No. 4)","content":"![](image.001.png)\n\nTherapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2010 (No. 4)\n\nI, ROHAN HAMMETT, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n-   oral preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that:\n    -   contain Docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp. as a therapeutically active ingredient in combination with other ingredients; and\n    -   are presented in a therapeutic dosage form for therapeutic use.\n\nThis Notice commences on the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 30th day of November 2010\n\n(signed by)\n\nRohan Hammett\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1932},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The notice operates precisely within the temporary listing power conferred by section 9A(5) of the Therapeutic Goods Act 1989, serving as an interim mechanism to allow specific goods to be listed while awaiting permanent regulatory amendment. No expansion beyond this specific statutory purpose has occurred."},"complexity_factors":["Single operative provision containing only two qualifying conditions","No defined terms section; relies on external references only for ingredient classification","Linear structure with no exceptions, exemptions, or conditional logic","Explicit sunset clause provides clear temporal limitation without requiring calculation"],"plain_english_summary":"This notice temporarily permits oral supplements containing DHA-rich oil from microalgae (Schizochytrium) to be supplied in Australia as listed medicines by requiring inclusion on the ARTG as listed goods. It affects manufacturers, suppliers and consumers of non-fish omega‑3 products by creating a legal, lower‑regulation pathway while formal regulations are updated. The measure is temporary and ceases once permanent regulatory amendments take effect."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2010-no-4","history":"/api/acts/therapeutic-goods-listing-notice-2010-no-4/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2010-no-4/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2010-no-4/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2010-no-4/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2010-no-4/documents"}}